Washington: The White House’s big pharma deal
The Takeaway’s Washington correspondent, Todd Zwillich, joins us with a look at a deal the White House reached earler this year with drug companies. The deal stipulated that pharmaceutical companies would cut name-brand drug prices by 50% for seniors who aren’t covered under Medicare’s drug plan. In exchange, the White House promised no further cuts to the pharmaceutical industry. While both the White House and Sen. Max Baucus (D-Mont.) want to honor the deal, some Democrats are appalled by the seeming kowtowing to special interests.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. If you’ve been thinking about making a donation, this is the best time to do it. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. All donations between now and June 30 will be matched 2:1. Will you help keep our newsroom on strong footing by giving to The World?